The Latest Breaking News from Vertex

Vertex announced promising test results for its opioid alternative on Thursday, sending VRTX stock deeper into breakout territory.

Without PBS subsidy, around 1,900 Australians would be up for more than $250,000 a year to access the CF drug.

A gene therapy by Vertex Pharma has turned out to be a money spinner for the company.

Vertex Inc (NASDAQ:VERX) reported fourth-quarter FY21 revenue growth of 12.2% year-on-year to $111.7 million, beating the consensus of $109.2 million. Software subscription revenues rose 11.1% Y/Y to $93.3 million, and Cloud revenues increased 38.9% Y/Y to $34.7 million. Drivers: Annual Recurring Revenue rose 17% Y/Y to $370.2 million. The Average Annual Revenue per customer…

  Vertex (NASDAQ:VERX) reported its Q4 earnings results on Wednesday, March 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Vertex Energy Inc (NASDAQ:VTNR) reported fourth-quarter revenue growth of 82.5% year-over-year to $31.79 million, beating the consensus of $29.37 million. Q4 Adjusted net income recovered to $4.64 million from a loss of $(2.74) million in 4Q20. The gross margin declined by 130 bps to 1%. The company reported an operating loss of $(7.46)…

Vertex (NASDAQ:VERX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-09. Here's what investors need to know before the announcement. Analysts estimate that Vertex will report an earnings per share (EPS) of $0.05.

Vectrus Inc (NYSE:VEC) entered a definitive agreement to combine with The Vertex Company in an all-stock merger. Vertex Company is headquartered in Madison, Mississippi, and employs ~6,000 employees. Vertex is majority-owned by American Industrial Partners Capital Fund VI LP. Vertex delivers integrated turnkey lifecycle support from concept definition to engineering and manufacturing.…

As Tesla, Nvidia and Microsoft struggle, CF Industries gets sold into strength and Union Pacific and Vertex try to buck the market correction.